EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Molekularne mechanizmy oporności na terapię w raku jajnika

Angelika Patelak, Julia Nowak-Niedźwiecka, Beata Machnicka

Postępy Biochemii · 07.06.2026 · 72 (2) · 67-84

DOI: 10.18388/5djwbt46 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Postępy Biochemii, online erschienen am 07.06.2026. Verfasst von Angelika Patelak und 2 weiteren Autor:innen. Beteiligte Einrichtung: Katedra Biotechnologii, Instytut Nauk Biologicznych, Uniwersytet Zielonogórski, Zielona Góra. Hauptthemen laut MEDLINE: Ovarian Neoplasms, Drug Resistance, Neoplasm, Antineoplastic Agents. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ovarian cancer remains one of the most frequently diagnosed and lethal gynaecological malignancies. Standard treatment involves surgical cytoreduction followed by chemotherapy based on platinum compounds and taxanes. Despite initial therapeutic efficacy, many patients experience disease recurrence and develop drug resistance, posing a significant clinical challenge. This review summarises the main molecular mechanisms underlying resistance to commonly used drugs, including paclitaxel, cisplatin, and PARP inhibitors. The role of multidrug resistance (MDR), associated with the overexpression of ABC transporters and alterations in drug metabolism, is discussed. Particular attention is given to cellular mechanisms, including changes in microtubule structure, regulation of apoptosis, and activation of signalling pathways such as PI3K/AKT/mTOR. Mechanisms related to drug transport, detoxification, and DNA repair are also addressed, together with the influence of the tumour microenvironment and epigenetic modifications. Understanding these mechanisms may contribute to the development of novel therapeutic strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ovarian NeoplasmsDrug Resistance, NeoplasmAntineoplastic AgentsHumansFemaleDrug Resistance, MultipleApoptosisSignal TransductionTOR Serine-Threonine Kinases

Substanzen

Antineoplastic AgentsTOR Serine-Threonine Kinases

Autor:innen und Institutionen

  • Katedra Biotechnologii, Instytut Nauk Biologicznych, Uniwersytet Zielonogórski, Zielona Góra.

Zitieren

APA

Patelak, A., Nowak-Niedźwiecka, J., & Machnicka, B. (2026). Molekularne mechanizmy oporności na terapię w raku jajnika. Postępy Biochemii, 72(2), 67-84. https://doi.org/10.18388/5djwbt46

Vancouver

Patelak A, Nowak-Niedźwiecka J, Machnicka B. Molekularne mechanizmy oporności na terapię w raku jajnika. Postępy Biochemii. 2026;72(2):67-84. doi:10.18388/5djwbt46

BibTeX
@article{Patelak2026,
  author = {Patelak, Angelika and Nowak-Niedźwiecka, Julia and Machnicka, Beata},
  title = {Molekularne mechanizmy oporności na terapię w raku jajnika},
  journal = {Postępy Biochemii},
  year = {2026},
  volume = {72},
  number = {2},
  pages = {67--84},
  doi = {10.18388/5djwbt46}
}
Kostenlos starten →